Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency ’s continued efforts to bring competition to the insulin market to lower prices and expand access

FDA is announcing a public hearing to discuss access to affordable insulin products.
Source: Food and Drug Administration - Category: American Health Source Type: news